Barclays’s Palvella Therapeutics PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$248K Sell
1,991
-23,145
-92% -$2.41M ﹤0.01% 3569
2025
Q4
$2.63M Buy
25,136
+15,360
+157% +$1.31M ﹤0.01% 2729
2025
Q3
$613K Sell
9,776
-2,403
-20% -$107K ﹤0.01% 3682
2025
Q2
$275K Buy
12,179
+12,116
+19,232% +$284K ﹤0.01% 4090
2025
Q1
$1.76K Hold
63
﹤0.01% 5003
2024
Q4
$756 Hold
63
﹤0.01% 5149
2024
Q3
$1.04K Hold
63
﹤0.01% 5123
2024
Q2
$618 Hold
63
﹤0.01% 4703
2024
Q1
$917 Hold
63
﹤0.01% 4950
2023
Q4
$911 Hold
63
﹤0.01% 5116
2023
Q3
$1.49K Sell
63
-10
-14% -$215 ﹤0.01% 4471
2023
Q2
$968 Sell
73
-404
-85% -$24.5K ﹤0.01% 4367
2023
Q1
$37.3K Buy
477
+11
+2% +$1.27K ﹤0.01% 4513
2022
Q4
$38.7K Hold
466
﹤0.01% 4636
2022
Q3
$43K Hold
466
﹤0.01% 3828
2022
Q2
$70K Sell
466
-508
-52% -$92.7K ﹤0.01% 3917
2022
Q1
$237K Hold
974
﹤0.01% 3321
2021
Q4
$294K Buy
974
+470
+93% +$151K ﹤0.01% 3430
2021
Q3
$209K Buy
504
+423
+522% +$147K ﹤0.01% 3602
2021
Q2
$24K Sell
81
-474
-85% -$104K ﹤0.01% 4443
2021
Q1
$114K Buy
555
+47
+9% +$10.3K ﹤0.01% 3947
2020
Q4
$102K Sell
508
-73
-13% -$15.2K ﹤0.01% 4129
2020
Q3
$97K Sell
581
-56
-9% -$12.8K ﹤0.01% 4273
2020
Q2
$158K Buy
637
+149
+31% +$34.8K ﹤0.01% 4238
2020
Q1
$89K Sell
488
-112
-19% -$28.2K ﹤0.01% 4883
2019
Q4
$173K Sell
600
-21
-3% -$5.82K ﹤0.01% 5142
2019
Q3
$170K Sell
621
-41
-6% -$15.9K ﹤0.01% 5094
2019
Q2
$249K Buy
662
+474
+252% +$141K ﹤0.01% 4916
2019
Q1
$50K Buy
188
+119
+172% +$28.3K ﹤0.01% 5878
2018
Q4
$15K Sell
69
-174
-72% -$54K ﹤0.01% 6035
2018
Q3
$109K Buy
243
+195
+406% +$84.7K ﹤0.01% 5471
2018
Q2
$20K Sell
48
-325
-87% -$155K ﹤0.01% 6200
2018
Q1
$204K Buy
373
+282
+310% +$175K ﹤0.01% 4816
2017
Q4
$55K Sell
91
-352
-79% -$164K ﹤0.01% 5698
2017
Q3
$205K Buy
+443
New +$189K ﹤0.01% 4406

Other funds holding PVLA